Literature DB >> 30068588

Creating Insertions or Deletions Using Overlap Extension Polymerase Chain Reaction (PCR) Mutagenesis.

Matteo Forloni, Alex Y Liu, Narendra Wajapeyee.   

Abstract

Overlap extension polymerase chain reaction (PCR) mutagenesis can be used for the generation of a specific point mutation, insertion, or deletion within a particular DNA sequence of interest. It requires relatively little preparation compared with other mutagenesis methods and does not require the use of restriction enzymes. Because of its versatility, the method has become widely used. Unlike methods of random mutagenesis, directed mutagenesis requires that the researcher already have a specific mutation in mind to implement. Traditional overlap extension PCR mutagenesis protocols remain limited in several critical ways, especially when it comes to generating insertions and deletions. For example, traditional protocols require that all sequence alterations be embedded within the primer itself, which makes it difficult to make insertions >30 nt. This protocol describes an overlap extension PCR mutagenesis method that is more versatile than its predecessors. Using this method, one can essentially make insertions and deletions of any size at any position within a given DNA sequence. To generate an insertion mutation, first prepare an insertion fragment and two flanking fragments by PCR. In the secondary PCR, the insertion fragment is recombined with two flanking fragments derived from the original template. This method can also be used to generate deletions, which is discussed in the latter part of the protocol.
© 2018 Cold Spring Harbor Laboratory Press.

Mesh:

Substances:

Year:  2018        PMID: 30068588     DOI: 10.1101/pdb.prot097758

Source DB:  PubMed          Journal:  Cold Spring Harb Protoc        ISSN: 1559-6095


  6 in total

1.  Optimization of overlap extension PCR for efficient transgene construction.

Authors:  Roland S Hilgarth; Thomas M Lanigan
Journal:  MethodsX       Date:  2019-12-04

2.  Poor neutralization and rapid decay of antibodies to SARS-CoV-2 variants in vaccinated dialysis patients.

Authors:  Jessica Bassi; Olivier Giannini; Chiara Silacci-Fregni; Laura Pertusini; Paolo Hitz; Tatiana Terrot; Yves Franzosi; Francesco Muoio; Christian Saliba; Marcel Meury; Exequiel A Dellota; Josh R Dillen; Patrick Hernandez; Nadine Czudnochowski; Elisabetta Cameroni; Nicola Beria; Mariangela Ventresca; Alberto Badellino; Soraya Lavorato-Hadjeres; Elisabetta Lecchi; Tecla Bonora; Matteo Mattiolo; Guido Trinci; Daniela Garzoni; Giuseppe Bonforte; Valentina Forni-Ogna; Davide Giunzioni; Lorenzo Berwert; Ravindra K Gupta; Paolo Ferrari; Alessandro Ceschi; Pietro Cippà; Davide Corti; Antonio Lanzavecchia; Luca Piccoli
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

3.  Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.

Authors:  Bo Meng; Steven A Kemp; Guido Papa; Rawlings Datir; Isabella A T M Ferreira; Sara Marelli; William T Harvey; Spyros Lytras; Ahmed Mohamed; Giulia Gallo; Nazia Thakur; Dami A Collier; Petra Mlcochova; Lidia M Duncan; Alessandro M Carabelli; Julia C Kenyon; Andrew M Lever; Anna De Marco; Christian Saliba; Katja Culap; Elisabetta Cameroni; Nicholas J Matheson; Luca Piccoli; Davide Corti; Leo C James; David L Robertson; Dalan Bailey; Ravindra K Gupta
Journal:  Cell Rep       Date:  2021-06-08       Impact factor: 9.995

4.  Customized one-step preparation of sgRNA transcription templates via overlapping PCR Using short primers and its application in vitro and in vivo gene editing.

Authors:  Zheng Hu; Li Wang; Zhaoying Shi; Jing Jiang; Xiangning Li; Yonglong Chen; Kai Li; Dixian Luo
Journal:  Cell Biosci       Date:  2019-10-24       Impact factor: 7.133

5.  SARS-CoV-2 B.1.1.7 sensitivity to mRNA vaccine-elicited, convalescent and monoclonal antibodies.

Authors:  Dami A Collier; Anna De Marco; Isabella A T M Ferreira; Bo Meng; Rawlings Datir; Alexandra C Walls; Steven A Kemp S; Jessica Bassi; Dora Pinto; Chiara Silacci Fregni; Siro Bianchi; M Alejandra Tortorici; John Bowen; Katja Culap; Stefano Jaconi; Elisabetta Cameroni; Gyorgy Snell; Matteo S Pizzuto; Alessandra Franzetti Pellanda; Christian Garzoni; Agostino Riva; Anne Elmer; Nathalie Kingston; Barbara Graves; Laura E McCoy; Kenneth Gc Smith; John R Bradley; Nigel Temperton; Lourdes Ceron-Gutierrez L; Gabriela Barcenas-Morales; William Harvey; Herbert W Virgin; Antonio Lanzavecchia; Luca Piccoli; Rainer Doffinger; Mark Wills; David Veesler; Davide Corti; Ravindra K Gupta
Journal:  medRxiv       Date:  2021-02-15

6.  Overexpression of wild type or a Q311E mutant MB21D2 promotes a pro-oncogenic phenotype in HNSCC.

Authors:  Daniel E Gracilla; Praveen Kumar Korla; Ming-Tsung Lai; An-Jen Chiang; Wen-Shiung Liou; Jim Jinn-Chyuan Sheu
Journal:  Mol Oncol       Date:  2020-10-15       Impact factor: 6.603

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.